| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.29 | 8e-08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.28 | 7e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |